Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 16/20 | 0.54 |
| ▸ | CDK2 | P24941 | 7/20 | 0.54 |
| ▸ | MAPKAPK2 | P49137 | 2/20 | 0.53 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.45 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13998623 | 0.99 | GSK3B (0.55) | GSK3BCDK2MAPKAPK2CSNK2BCSNK2A1 | |
| SCHEMBL13998535 | 0.84 | GSK3B (0.70) | GSK3BCDK2 | |
| SCHEMBL13998510 | 0.84 | GSK3B (0.46) | GSK3BCDK2MAPKAPK2 | |
| SCHEMBL13998539 | 0.84 | GSK3B (0.46) | GSK3BCDK2MAPKAPK2 | |
| SCHEMBL13118315 | 0.83 | GSK3B (0.74) | GSK3BCDK2 | |
| SCHEMBL13998473 | 0.82 | GSK3B (0.52) | GSK3BCDK2 | |
| SCHEMBL12953403 | 0.82 | GSK3B (0.73) | GSK3BCDK2 | |
| SCHEMBL13309212 | 0.81 | CDK2 (0.58) | GSK3BCDK2MAPKAPK2CSNK2B | |
| SCHEMBL12954157 | 0.80 | GSK3B (0.73) | GSK3BCDK2 | |
| SCHEMBL11931138 | 0.79 | GSK3B (0.45) | GSK3BCDK2MAPKAPK2CSNK2BCSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7470695-B2 | N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors | SCHERING CORPORATION (US) | 2008-12-30 | — | — | US | disclosed |
| US-7470695-B2 | N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors | SCHERING CORPORATION (US) | 2008-12-30 | — | — | US | disclosed |
| EP-1534709-B1 | PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS | SCHERING CORP (US) | 2007-06-13 | — | — | EP | disclosed |
| WO-2007044401-A2 | NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS | SCHERING CORPORATION (US) | 2007-04-19 | — | — | WO | disclosed |
| US-7196092-B2 | N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors | SCHERING CORPORATION (US) | 2007-03-27 | — | — | US | disclosed |
| US-7196092-B2 | N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors | SCHERING CORPORATION (US) | 2007-03-27 | — | — | US | disclosed |